Woodline Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Woodline Partners's AMGN Position: Q1 2026 in Review
Woodline Partners increased its Amgen (AMGN) stake by 13% in Q1 2026, buying an estimated $8.68M and bringing the position to 205,802 shares worth $72.4M. The position accounts for 0.27% of the portfolio, ranked #77.
Woodline Partners first reported a position in AMGN in Q4 2019 and has held it in 21 quarters since. The position peaked at $115M in Q4 2020. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Woodline Partners held 205,802 shares of Amgen worth $72.4M as of Q1 2026.
- Woodline Partners bought 24,348 Amgen shares in Q1 2026, an estimated $8.68M.
- Amgen made up 0.27% of Woodline Partners's portfolio in Q1 2026, its #77 holding.
- Woodline Partners first reported a position in Amgen in Q4 2019 and has held it in 21 quarters since.
- Woodline Partners's Amgen position peaked at $115M in Q4 2020.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.